Development of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain.
Asahi TomitakaHamed AramiAndrea RaymondAdriana YndartAjeet KaushikRahul Dev JayantYasushi TakemuraYong CaiMichal ToborekMadhavan NairPublished in: Nanoscale (2018)
Magneto-plasmonic nanoparticles are one of the emerging multi-functional materials in the field of nanomedicine. Their potential for targeting and multi-modal imaging is highly attractive. In this study, magnetic core/gold shell (MNP@Au) magneto-plasmonic nanoparticles were synthesized by citrate reduction of Au ions on magnetic nanoparticle seeds. Hydrodynamic size and optical properties of magneto-plasmonic nanoparticles synthesized with the variation of Au ions and reducing agent concentrations were evaluated. The synthesized magneto-plasmonic nanoparticles exhibited superparamagnetic properties, and their magnetic properties contributed to the concentration-dependent contrast in magnetic resonance imaging (MRI). The imaging contrast from the gold shell part of the magneto-plasmonic nanoparticles was also confirmed by X-ray computed tomography (CT). The transmigration study of the magneto-plasmonic nanoparticles using an in vitro blood-brain barrier (BBB) model proved enhanced transmigration efficiency without disrupting the integrity of the BBB, and showed potential to be used for brain diseases and neurological disorders.
Keyphrases
- blood brain barrier
- magnetic resonance imaging
- computed tomography
- single molecule
- contrast enhanced
- high resolution
- magnetic resonance
- cerebral ischemia
- label free
- dual energy
- visible light
- sensitive detection
- quantum dots
- molecularly imprinted
- walled carbon nanotubes
- stem cells
- positron emission tomography
- multiple sclerosis
- image quality
- bone marrow
- reduced graphene oxide
- human health
- diffusion weighted imaging
- chronic pain
- pet ct
- subarachnoid hemorrhage
- climate change
- water soluble